HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109. A total of 80 filers reported holding HARROW HEALTH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,262,721 | -54.3% | 87,872 | -39.5% | 0.00% | -57.1% |
Q2 2023 | $2,765,979 | -52.5% | 145,272 | -47.2% | 0.01% | -58.8% |
Q1 2023 | $5,822,111 | +79.4% | 275,147 | +25.2% | 0.02% | +70.0% |
Q4 2022 | $3,244,425 | +134.9% | 219,812 | +92.2% | 0.01% | +100.0% |
Q3 2022 | $1,381,000 | +72.8% | 114,393 | +4.2% | 0.01% | +66.7% |
Q2 2022 | $799,000 | +49.1% | 109,750 | +39.7% | 0.00% | +50.0% |
Q1 2022 | $536,000 | -52.9% | 78,557 | -40.3% | 0.00% | 0.0% |
Q4 2021 | $1,137,000 | -47.4% | 131,601 | -44.7% | 0.00% | -60.0% |
Q3 2021 | $2,163,000 | -25.4% | 237,899 | -23.8% | 0.01% | -28.6% |
Q2 2021 | $2,900,000 | +62.4% | 312,174 | +18.0% | 0.01% | +40.0% |
Q1 2021 | $1,786,000 | +53.0% | 264,599 | +55.6% | 0.01% | +66.7% |
Q4 2020 | $1,167,000 | +26.8% | 170,087 | +3.4% | 0.00% | 0.0% |
Q3 2020 | $920,000 | +829.3% | 164,514 | +769.5% | 0.00% | – |
Q2 2020 | $99,000 | -80.2% | 18,920 | -67.1% | 0.00% | -100.0% |
Q2 2019 | $500,000 | -23.9% | 57,458 | -56.4% | 0.00% | 0.0% |
Q1 2019 | $657,000 | – | 131,877 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,065,416 | $21,029,000 | 2.75% |
Diametric Capital, LP | 252,774 | $1,734,000 | 1.38% |
Birchview Capital, LP | 180,000 | $1,235,000 | 0.71% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 118,389 | $812,000 | 0.61% |
Zebra Capital Management LLC | 58,062 | $398,000 | 0.50% |
Precision Wealth Strategies, LLC | 62,739 | $430,000 | 0.47% |
Sio Capital Management, LLC | 209,623 | $1,438,000 | 0.29% |
Uniplan Investment Counsel, Inc. | 505,746 | $3,469,000 | 0.24% |
CORRADO ADVISORS, LLC | 31,580 | $217,000 | 0.17% |
BARD ASSOCIATES INC | 287,250 | $1,970,000 | 0.16% |